323 related articles for article (PubMed ID: 37143154)
1. Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced: the PUMA trial.
Regnery S; de Colle C; Eze C; Corradini S; Thieke C; Sedlaczek O; Schlemmer HP; Dinkel J; Seith F; Kopp-Schneider A; Gillmann C; Renkamp CK; Landry G; Thorwarth D; Zips D; Belka C; Jäkel O; Debus J; Hörner-Rieber J
Radiat Oncol; 2023 May; 18(1):74. PubMed ID: 37143154
[TBL] [Abstract][Full Text] [Related]
2. Treating locally advanced lung cancer with a 1.5T MR-Linac - Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy.
Bainbridge HE; Menten MJ; Fast MF; Nill S; Oelfke U; McDonald F
Radiother Oncol; 2017 Nov; 125(2):280-285. PubMed ID: 28987747
[TBL] [Abstract][Full Text] [Related]
3. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3).
Regnery S; Ristau J; Weykamp F; Hoegen P; Sprengel SD; Paul KM; Buchele C; Klüter S; Rippke C; Renkamp CK; Pohl M; Meis J; Welzel T; Adeberg S; Koerber SA; Debus J; Hörner-Rieber J
Radiat Oncol; 2022 May; 17(1):102. PubMed ID: 35614486
[TBL] [Abstract][Full Text] [Related]
5. Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
Finazzi T; Palacios MA; Spoelstra FOB; Haasbeek CJA; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):933-941. PubMed ID: 30928360
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen.
Henke L; Kashani R; Robinson C; Curcuru A; DeWees T; Bradley J; Green O; Michalski J; Mutic S; Parikh P; Olsen J
Radiother Oncol; 2018 Mar; 126(3):519-526. PubMed ID: 29277446
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: preclinical and early clinical data.
Reboul FL
Hematol Oncol Clin North Am; 2004 Feb; 18(1):41-53. PubMed ID: 15005280
[TBL] [Abstract][Full Text] [Related]
8. Functional lung avoidance for individualized radiotherapy (FLAIR): study protocol for a randomized, double-blind clinical trial.
Hoover DA; Capaldi DP; Sheikh K; Palma DA; Rodrigues GB; Dar AR; Yu E; Dingle B; Landis M; Kocha W; Sanatani M; Vincent M; Younus J; Kuruvilla S; Gaede S; Parraga G; Yaremko BP
BMC Cancer; 2014 Dec; 14():934. PubMed ID: 25496482
[TBL] [Abstract][Full Text] [Related]
9. Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis.
Eze C; Taugner J; Roengvoraphoj O; Schmidt-Hegemann NS; Käsmann L; Wijaya C; Belka C; Manapov F
Radiat Oncol; 2019 Sep; 14(1):163. PubMed ID: 31484542
[TBL] [Abstract][Full Text] [Related]
10. MR-guided radiotherapy in node-positive non-small cell lung cancer and severely limited pulmonary reserve: a report proposing a new clinical pathway for the management of high-risk patients.
Eze C; Lombardo E; Nierer L; Xiong Y; Niyazi M; Belka C; Manapov F; Corradini S
Radiat Oncol; 2022 Feb; 17(1):43. PubMed ID: 35209922
[TBL] [Abstract][Full Text] [Related]
11. A daily end-to-end quality assurance workflow for MR-guided online adaptive radiation therapy on MR-Linac.
Chen X; Ahunbay E; Paulson ES; Chen G; Li XA
J Appl Clin Med Phys; 2020 Jan; 21(1):205-212. PubMed ID: 31799753
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance (MR) imaging for tumor staging and definition of tumor volumes on radiation treatment planning in nonsmall cell lung cancer: A prospective radiographic cohort study of single center clinical outcome.
Zhao D; Hu Q; Qi L; Wang J; Wu H; Zhu G; Yu H
Medicine (Baltimore); 2017 Feb; 96(8):e5943. PubMed ID: 28225485
[TBL] [Abstract][Full Text] [Related]
13. Synthetic 4D-CT of the thorax for treatment plan adaptation on MR-guided radiotherapy systems.
Freedman JN; Bainbridge HE; Nill S; Collins DJ; Kachelrieß M; Leach MO; McDonald F; Oelfke U; Wetscherek A
Phys Med Biol; 2019 May; 64(11):115005. PubMed ID: 30844775
[TBL] [Abstract][Full Text] [Related]
14. MR-guidance--a clinical study to evaluate a shuttle- based MR-linac connection to provide MR-guided radiotherapy.
Bostel T; Nicolay NH; Grossmann JG; Mohr A; Delorme S; Echner G; Häring P; Debus J; Sterzing F
Radiat Oncol; 2014 Jan; 9():12. PubMed ID: 24401489
[TBL] [Abstract][Full Text] [Related]
15. Online Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical Applications.
Acharya S; Fischer-Valuck BW; Kashani R; Parikh P; Yang D; Zhao T; Green O; Wooten O; Li HH; Hu Y; Rodriguez V; Olsen L; Robinson C; Michalski J; Mutic S; Olsen J
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):394-403. PubMed ID: 26678659
[TBL] [Abstract][Full Text] [Related]
16. Cone-beam CT-guided radiotherapy in the management of lung cancer: Diagnostic and therapeutic value.
Elsayad K; Kriz J; Reinartz G; Scobioala S; Ernst I; Haverkamp U; Eich HT
Strahlenther Onkol; 2016 Feb; 192(2):83-91. PubMed ID: 26630946
[TBL] [Abstract][Full Text] [Related]
17. Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study.
Haslett K; Bayman N; Franks K; Groom N; Harden SV; Harris C; Hanna G; Harrow S; Hatton M; McCloskey P; McDonald F; Ryder WD; Faivre-Finn C
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1341-1348. PubMed ID: 33232772
[TBL] [Abstract][Full Text] [Related]
18. Accelerated hypofractionated magnetic resonance-guided adaptive radiotherapy for oligoprogressive non-small cell lung cancer.
La Rosa A; Mittauer KE; Chuong MD; Hall MD; Kutuk T; Bassiri N; McCulloch J; Alvarez D; Herrera R; Gutierrez AN; Tolakanahalli R; Mehta MP; Kotecha R
Med Dosim; 2023 Winter; 48(4):238-244. PubMed ID: 37330328
[TBL] [Abstract][Full Text] [Related]
19. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
Schaule J; Chamberlain M; Wilke L; Baumgartl M; Krayenbühl J; Zamburlini M; Mayinger M; Andratschke N; Tanadini-Lang S; Guckenberger M
Radiat Oncol; 2021 Sep; 16(1):189. PubMed ID: 34565439
[TBL] [Abstract][Full Text] [Related]
20. Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy.
Tekatli H; Palacios MA; Schneiders FL; Haasbeek CJA; Slotman BJ; Lagerwaard FJ; Senan S
Radiother Oncol; 2023 Oct; 187():109823. PubMed ID: 37516364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
